HOW ELEXACAFTOR/TEZACAFTOR/IVACAFTOR IS CHANGING SPUTUM CULTURE COLLECTION FOR PEOPLE WITH CYSTIC FIBROSIS

被引：0
|
作者：
Pai, S. [1 ]
Villagomez, K. [2 ]
Dorsett, S. [3 ]
Guthrie, C. P. [4 ]
机构：
[1] Dell Childrens Med Ctr Cent Texas, Pediat CF Ctr Specialty Care, Austin, TX USA
[2] Ascens Seton Med Ctr Austin, Adult CF Ctr Cent Texas, Austin, TX USA
[3] Univ Hlth Syst, CF Ctr, San Antonio, TX USA
[4] UT Hlth Tyler North Campus, Cyst Fibrosis Ctr & Pulm Clin, Tyler, TX USA
来源：
PEDIATRIC PULMONOLOGY | 2020年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
569
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [41] Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis
    Stapleton, Amanda L.
    Kimple, Adam J.
    Goralski, Jennifer L.
    Nouraie, S. Mehdi
    Branstetter, Barton F.
    Shaffer, Amber
    Pilewski, Joseph M.
    Senior, Brent A.
    Lee, Stella E.
    Zemke, Anna C.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (05) : 792 - 799
  • [42] Exercise tolerance in cystic fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor
    Hrvoic, Lovro
    Bambir, Ivan
    Omerza, Lana
    Todoric, Ivana
    Markelic, Ivona
    Dugac, Andrea Vukic
    Tjesic-Drinkovic, Duska
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [43] Peripheral lung effect of elexacaftor/tezacaftor/ivacaftor in adult cystic fibrosis
    Stylemans, Dimitri
    Darquenne, Chantal
    Schuermans, Daniel
    Verbanck, Sylvia
    Vanderhelst, Eef
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (01) : 160 - 163
  • [44] Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces Aspergillus fumigatus in Cystic Fibrosis
    Morgan, Sarah J.
    Nichols, David P.
    Ni, Windy
    Hong, Gina
    Salipante, Stephen J.
    Solomon, George M.
    Rowe, Steven M.
    Clancy, John P.
    Cramer, Robert A.
    Singh, Pradeep K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 210 (09) : 1155 - 1158
  • [45] The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis
    Scully, Kevin J.
    Marchetti, Peter
    Sawicki, Gregory S.
    Uluer, Ahmet
    Cernadas, Manuela
    Cagnina, Rebecca E.
    Kennedy, John C.
    Putman, Melissa S.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (02) : 258 - 263
  • [46] Elexacaftor/Tezacaftor/Ivacaftor as a Bridge to Lung Retransplant in a Recipient With Cystic Fibrosis
    FitzMaurice, Thomas Simon
    Nazareth, Dilip
    Iyer, Kapil
    Walshaw, Martin
    Al-Aloul, Mohamed
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (04) : 433 - 435
  • [47] Development of elexacaftor - tezacaftor - ivacaftor: Highly effective CFTR modulation for the majority of people with Cystic Fibrosis
    Middleton, Peter G.
    Taylor-Cousar, Jennifer L.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (06) : 723 - 735
  • [48] EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON ANNUAL RATE OF LUNG FUNCTION DECLINE IN PEOPLE WITH CYSTIC FIBROSIS
    Lee, Tim
    Sawicki, Gregory S.
    Altenburg, Josje
    Millar, Stefanie J.
    Geiger, Jessica Morlando
    Jennings, Mark T.
    Lou, Yiyue
    McGarry, Lisa J.
    Van Brunt, Kate
    Linnemann, Rachel W.
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (03) : 402 - 406
  • [49] Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease
    Hernandez, Laura Carrasco
    Moreno, Rosa Ma Giron
    Cartagena, Mari Nieves Balaguer
    Pelaez, Adrian
    Sole, Amparo
    Fernandez, Antonio Alvarez
    Montiel, Almudena Felipe
    Olveira, Casilda
    Olveira, Gabriel
    Bonilla, Ainhoa Gomez
    Crespo, Beatriz Gomez
    Clemente, Marta Garcia
    Garcia, Marta Solis
    Vazquez, Joana Quaresma
    Castro, Enrique Blitz
    Gonzalez, Jesus Rodriguez
    Marrero, Andrea Exposito
    Diab-Caceres, Laila
    Hernandez, Cristina Ramos
    de Lucas, Ester Zamarron
    Sanchez, Concha Prados
    Aparicio, Marina Blanco
    Neyra, Alejandro Lopez
    Santiago, Veronica Sanz
    Paredes, Carmen Luna
    Pecellin, Isabel Delgado
    de la Cruz, Oscar Asensio
    Gallego, Esther Quintana
    ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59 (09): : 556 - 565
  • [50] ELEXACAFTOR/TEZACAFTOR/IVACAFTOR CLINICAL EXPERIENCE IN ADULT CYSTIC FIBROSIS PATIENTS
    Finke, J. H.
    Indihar, M.
    Khawar, M.
    Kopras, E.
    Galloway, J.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S226 - S226
12345